Buck D, Kroner A, Rieckmann P, Mäurer M, Wiendl H
Clinical Research Group for Multiple Sclerosis and Neuroimmunology, Department of Neurology, Bayerische Julius-Maximilians Universität, Würzburg, Germany.
Tissue Antigens. 2006 Oct;68(4):335-8. doi: 10.1111/j.1399-0039.2006.00672.x.
The costimulatory CD40-CD40L pathway plays a critical role in the generation and maintenance of adaptive immune responses. Genetic interference of CD40-CD40L interactions strongly influences the onset and course in many autoimmune disease models including experimental autoimmune encephalomyelitis. We analysed the association of a single nucleotide polymorphism of the CD40 gene (C/T(-1)) in 287 patients with multiple sclerosis (MS) and 184 matched controls. No significant differences were found in the frequency of the C/T(-1) polymorphism between the patients with MS and the controls (53% vs 49%) or among different MS subtypes. Cell surface expression of CD40 did not differ within the different genotypes, but carriers of the T allele showed a trend for a lower stimulatory index compared with individuals with the CC genotype. Although these subtle differences indicate functional consequences in the immune stimulatory capabilities related to the CD40 C/T(-1) polymorphism, our population-based study found no association with disease susceptibility or disease course in MS.
共刺激CD40-CD40L途径在适应性免疫反应的产生和维持中起关键作用。CD40-CD40L相互作用的基因干扰在包括实验性自身免疫性脑脊髓炎在内的许多自身免疫性疾病模型中强烈影响发病和病程。我们分析了287例多发性硬化症(MS)患者和184例匹配对照中CD40基因单核苷酸多态性(C/T(-1))的相关性。MS患者与对照之间(53%对49%)或不同MS亚型之间,C/T(-1)多态性频率未发现显著差异。不同基因型内CD40的细胞表面表达无差异,但与CC基因型个体相比,T等位基因携带者的刺激指数有降低趋势。尽管这些细微差异表明与CD40 C/T(-1)多态性相关的免疫刺激能力存在功能后果,但我们基于人群的研究未发现其与MS的疾病易感性或病程有关联。